Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.

Cao, Ting-Ting; Lin, Shu-Hai; Fu, Li; Tang, Zhi; Che, Chi-Ming; Zhang, Li-Yi; Ming, Xiao-Yan; Liu, Teng-Fei; Tang, Xu-Ming; Tan, Bin-Bin; Xiang, Di; Li, Feng; Chan, On-Yee; Xie, Dan; Cai, Zongwei; Guan, Xin-Yuan

Cao, Ting-Ting; Lin, Shu-Hai; Fu, Li; Tang, Zhi; Che, Chi-Ming; Zhang, Li-Yi; Ming, Xiao-Yan; Liu, Teng-Fei; Tang, Xu-Ming; Tan, Bin-Bin; Xiang, Di; Li, Feng; Chan, On-Yee; Xie, Dan; Cai, Zongwei; Guan, Xin-Yuan.

Afiliação

Cao TT; Department of Pharmacology, Shenzhen Key Laboratory of Translational Medicine of Tumor and Cancer Research Centre, School of Medicine, Shenzhen University, Shenzhen, China.
Lin SH; Department of Clinical Oncology and.
Fu L; Centre for Cancer Research, University of Hong Kong, Hong Kong, China.
Tang Z; Department of Chemistry and State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, China.
Che CM; Department of Pharmacology, Shenzhen Key Laboratory of Translational Medicine of Tumor and Cancer Research Centre, School of Medicine, Shenzhen University, Shenzhen, China.
Zhang LY; Department of Chemistry and State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, China.
Ming XY; Department of Chemistry and.
Liu TF; Department of Clinical Oncology and.
Tang XM; Centre for Cancer Research, University of Hong Kong, Hong Kong, China.
Tan BB; Department of Clinical Oncology and.
Xiang D; Centre for Cancer Research, University of Hong Kong, Hong Kong, China.
Li F; Department of Chemistry and State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, China.
Chan OY; School of Biomedical Sciences, University of Hong Kong, Hong Kong, China.
Xie D; Department of Pharmacology, Shenzhen Key Laboratory of Translational Medicine of Tumor and Cancer Research Centre, School of Medicine, Shenzhen University, Shenzhen, China.
Cai Z; Department of Pharmacology, Shenzhen Key Laboratory of Translational Medicine of Tumor and Cancer Research Centre, School of Medicine, Shenzhen University, Shenzhen, China.
Guan XY; Wuhan University Shenzhen Research Institute, Shenzhen, China.

Carcinogenesis ; 38(1): 94-104, 2017 01.

Article em En | MEDLINE | ID: mdl-27879277

Assuntos

Biomarcadores Tumorais/metabolismo; Carcinoma Hepatocelular/metabolismo; Glucose/metabolismo; Lipogênese; Neoplasias Hepáticas/metabolismo; Redes e Vias Metabólicas; Fatores de Iniciação de Peptídeos/metabolismo; Proteínas de Ligação a RNA/metabolismo; Carcinoma Hepatocelular/genética; Carcinoma Hepatocelular/patologia; Estudos de Casos e Controles; Proliferação de Células; Células Cultivadas; Reprogramação Celular; Feminino; Seguimentos; Regulação Neoplásica da Expressão Gênica; Glicólise; Humanos; Fígado/metabolismo; Fígado/patologia; Neoplasias Hepáticas/genética; Neoplasias Hepáticas/patologia; Masculino; Pessoa de Meia-Idade; Invasividade Neoplásica; Estadiamento de Neoplasias; Fatores de Iniciação de Peptídeos/genética; Prognóstico; Proteínas de Ligação a RNA/genética; Taxa de Sobrevida; Fator de Iniciação de Tradução Eucariótico 5A

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Fatores de Iniciação de Peptídeos / Proteínas de Ligação a RNA / Carcinoma Hepatocelular / Lipogênese / Redes e Vias Metabólicas / Glucose / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Carcinogenesis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google